Gain Therapeutics Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gain therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gain Therapeutics Company Profile Today - Breaking & Trending Today

Gain Therapeutics (NASDAQ:GANX) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Gain Therapeutics (NASDAQ:GANX – Free Report) in a report issued on Wednesday morning, Benzinga reports. HC Wainwright currently has a $9.00 target price on the stock. GANX has been the topic of a number of other reports. Chardan Capital reissued a buy rating and set a […] ....

Jeffrey Scott Riley , Securities Exchange Commission , Gain Therapeutics Inc , Gain Therapeutics Company Profile , Gain Therapeutics , Free Report , Get Free Report , Director Jeffrey Scott Riley , Exchange Commission , Gain Therapeutics Daily ,

Gain Therapeutics, Inc. (NASDAQ:GANX) Sees Significant Growth in Short Interest

Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 149,600 shares, a growth of 8.3% from the March 31st total of 138,100 shares. Currently, 1.1% of the company’s shares are short sold. Based on an […] ....

Jeffrey Scott Riley , Gain Therapeutics Company Profile , Gain Therapeutics Inc , Gain Therapeutics , Get Free Report , Director Jeffrey Scott Riley , Gain Therapeutics Daily , Nasdaq Ganx ,

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Jeffrey Scott Riley , Gain Therapeutics Inc , Gain Therapeutics Company Profile , Gain Therapeutics , Free Report , Get Free Report , Director Jeffrey Scott Riley , Gain Therapeutics Daily ,

Gain Therapeutics, Inc. (NASDAQ:GANX) Director Jeffrey Scott Riley Acquires 30,000 Shares

Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) Director Jeffrey Scott Riley bought 30,000 shares of the business’s stock in a transaction on Thursday, March 28th. The shares were acquired at an average cost of $3.86 per share, for a total transaction of $115,800.00. Following the purchase, the director now directly owns 30,000 shares in […] ....

Jeffrey Scott Riley , Newedge Advisors , Renaissance Technologies , Securities Exchange Commission , Susquehanna International Group , Dimensional Fund Advisors , Gain Therapeutics Company Profile , Gain Therapeutics Inc , Gain Therapeutics , Get Free Report , Director Jeffrey Scott Riley , Exchange Commission , Fund Advisors , Street Group , Edge Advisors , International Group , Chardan Capital , Gain Therapeutics Daily , Nasdaq Ganx , Insider Trading , Nsider Trades ,

Gain Therapeutics, Inc. Expected to Post Q1 2024 Earnings of ($0.46) Per Share (NASDAQ:GANX)

Gain Therapeutics, Inc. Expected to Post Q1 2024 Earnings of ($0.46) Per Share (NASDAQ:GANX)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United Kingdom General , United Kingdom , Gain Therapeutics Inc , Dimensional Fund Advisors , Gain Therapeutics Company Profile , Newedge Advisors , Susquehanna International Group , Blackrock Inc , Gain Therapeutics , Free Report , Gain Therapeutic , Chardan Capital , Edge Advisors , Street Group , Fund Advisors , International Group , Get Free Report , Site Directed Enzyme Enhancement Therapy , Gain Therapeutics Daily ,